IMMUNE-MEDIATED HYPOPHYSITIS

This adverse event was reported 451 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED HYPOPHYSITIS:

# Drug Count
0 NIVOLUMAB 224
1 PEMBROLIZUMAB 191
2 IPILIMUMAB 186
3 CARBOPLATIN 97
4 PACLITAXEL 64
5 PACLITAXEL (AIBUMIN-BOUND) 63
6 CYCLOPHOSPHAMIDE 41
7 CYCLOPHOSPHAMIDE FOR INJECTION 41
8 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 41
9 BEVACIZUMAB 20
See all common drugs associated with IMMUNE-MEDIATED HYPOPHYSITIS

IMMUNE-MEDIATED HYPOPHYSITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IPILIMUMAB 186 0.0042
1 TREMELIMUMAB 13 0.0029
2 NIVOLUMAB 224 0.0023
3 PEMBROLIZUMAB 191 0.0018
4 EPIRUBICIN HYDROCHLORIDE 11 0.0017
5 DURVALUMAB 17 0.0008
6 CARBOPLATIN 97 0.0007
7 PACLITAXEL 64 0.0006
8 VANCOMYCIN HYDROCHLORIDE 4 0.0005
9 LENVATINIB 15 0.0004
See all drugs enriched for association with IMMUNE-MEDIATED HYPOPHYSITIS